Huibin Lv

6.3k citations
53 papers · 2.3k indexed · 1 hit paper · h-index 18
Topics
Ocular Surface and Contact Lens (13 papers)SARS-CoV-2 and COVID-19 Research (11 papers)Influenza Virus Research Studies (11 papers)

In The Last Decade

Huibin Lv

51 papers receiving 2.3k citations

Hit Papers

A highly conserved cryptic epitope in the receptor bindin...20202026202220242020250500750

Peers

Huibin Lv
Comparison fields: 5 of 131
  • Infectious Diseases 1.4k
  • Molecular Biology 520
  • Radiology, Nuclear Medicine and Imaging 510
  • Ophthalmology 289
  • Epidemiology 234
Replace Zhijie Li with:
Zhijie Li China
Yongjian Wu China
Lan Wang China
Chunyan Wang China
Haiyan Zhao China
Dae‐Gyun Ahn South Korea
Zhigang Wu China
Zhuoming Liu United States
Shuang Li China
John T. West United States
Huibin Lv relative to Zhijie Li China Zhijie Li's profile →
Citations per field
00.5×4.5×
Zhijie Li · 1×
Citations per year

Countries citing papers authored by Huibin Lv

Since Specialization
Citations

This map shows the geographic impact of Huibin Lv's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Huibin Lv with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Huibin Lv more than expected).

Fields of papers citing papers by Huibin Lv

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Huibin Lv. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Huibin Lv. The network helps show where Huibin Lv may publish in the future.

Co-authorship network of co-authors of Huibin Lv

This figure shows the co-authorship network connecting the top 25 collaborators of Huibin Lv. A scholar is included among the top collaborators of Huibin Lv based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Huibin Lv. Huibin Lv is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
#WorkIndexed citations
1 0
2 1
3 2
4 1
5 1
6 9
7 2
8 1
9 1
10 6
11 7
12 12
13 14
14 54
15 14
16 41
17 20
18 10
19 13
20 10

About Huibin Lv

Huibin Lv is a scholar working on Ophthalmology, Radiology, Nuclear Medicine and Imaging and Infectious Diseases, having authored 53 papers that have together received 2.3k indexed citations. Recurring topics across this work include Ocular Surface and Contact Lens (13 papers), SARS-CoV-2 and COVID-19 Research (11 papers) and Influenza Virus Research Studies (11 papers). The work is most often cited by research in Infectious Diseases (1.4k citations), Ophthalmology (289 citations) and Radiology, Nuclear Medicine and Imaging (510 citations). Huibin Lv has collaborated with scholars based in China, United States and Hong Kong. Frequent co-authors include Nicholas C. Wu, Chris Ka Pun Mok, Ian A. Wilson, Meng Yuan, Ray T. Y. So, Chang‐Chun D. Lee, Xueyong Zhu, Xuemin Li, Mingzhou Zhang and Xiaodan Jiang. Their work appears in journals such as Science, The Journal of Experimental Medicine and Immunity.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026